Canexis Pharma AG

Founded in 2020, Canexis Pharma AG specializes in the research and development of pharmaceutical cannabis products. Its own production facility in Schlattingen, Canton of Thurgau, meets the highest quality and safety standards. The manufacturing and narcotics licenses from Swissmedic allow Canexis to create innovative and safe pharmaceutical products, thereby enhancing the quality of life for patients.

View full article